The economic costs of schizophrenia. Implications for public policy.
The direct and indirect costs associated with schizophrenia in Australia were calculated using the incidence approach and compared with similar costings of myocardial infarction in Australia and the United States. In Australia schizophrenia affects one-twelfth as many people as does myocardial infarction, yet costs half as much. This is because the stream of costs associated with each case of schizophrenia is six times the stream of costs associated with myocardial infarction. To illustrate the utility of this costing approach, the information was used to estimate the cost-benefit ratio likely to follow the introduction of social intervention strategies. The information also showed that Australian support for research in schizophrenia is inadequate when compared with that for myocardial infarction and quite out of proportion to the cost of schizophrenia to the community.
D000293:Adolescent; D000328:Adult; D001315:Australia; D002648:Child; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003431:Cross-Cultural Comparison; D004180:Direct Service Costs; D005260:Female; D006291:Health Policy / Q000191:economics; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007182:Income; D007358:Insurance, Psychiatric / Q000191:economics; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000191:economics / Q000453:epidemiology; D012109:Research Support as Topic / Q000191:economics; D012559:Schizophrenia / Q000191:economics* / Q000453:epidemiology; D014481:United States